Form D · Biotechnology
ViaCyte Inc.
San Diego, CA · CIK 0001581903
Offering snapshot reported Apr 22, 2021 · SEC filing
- Reported sold
- $53.9M Offering amount: $58.5M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 6, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 22, 2021 | Initial | $53,931,166 | No comparison | 22 | SEC filing |
| Apr 2, 2020 | Initial | $32,645,780 | No comparison | 17 | SEC filing |
| Dec 3, 2018 | Initial | $35,833,603 | No comparison | 9 | SEC filing |
| Aug 21, 2014 | Initial | $15,000,000 | No comparison | 1 | SEC filing |
| Jul 19, 2013 | Initial | $12,150,824 | No comparison | 55 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-396782
Includes amounts paid both in cash and pursuant to automatic conversion of indebtedness.
Source: Form D, filed Apr 22, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven R. Altman | Director |
| Brittany Bradrick | Executive |
| Elizabeth Bui | Executive |
| Liz Bui | Executive |
| Kevin D'amour | Executive |
| Donald J. Elmer | Director |
| Mark G. Foletta | Director |
| Howard Foyt | Executive |
| Paul Hastings | Director |
| Lucian Iancovici | Director |
| Franklin P. Johnson | Director |
| Orville G. Kolterman | Director |
| Adam Koppel | Director |
| Steve Kradjian | Executive |
| Paul Laikind | Director, Executive |
| Heath Lukatch | Director |
| Fred A. Middleton | Director |
| Sandra Poole | Director |
| Allan Robin | Executive |
| Allan Robins | Executive |
| Anne Sandan | Executive |
| Michael Scott | Executive |
| Ian Smith | Director |
| Steve White | Executive |
| Asish Xavier | Director |
| Michael Yang | Director, Executive |
| Amir Zamani | Director |
| Mark Zimmerman | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3550 General Atomics Court
San Diego, CA, 92121
San Diego, CA, 92121